Drug Trial Radar · NCT07334080
ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants
Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
72
Planned (sponsor's estimate)
Start
Jan 7, 2026
Primary completion
Apr 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- EccogeneIndustry
- Sponsor type
- Industry
- First posted
- Jan 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase I, open-label, randomized, single-dose, 2-part study designed to evaluate the food effect and relative bioavailability of ECC4703 in healthy adult participants.
Conditions
- Metabolic Dysfunction-Associated Steatohepatitis
Interventions
ECC4703 F0 formulationDrug
A single dose of ECC4703 F0
ECC4703 F1 formulationDrug
A single dose of ECC4703 F1
ECC4703 F2 formulationDrug
A single dose of ECC4703 F2
ECC4703 F3 formulationDrug
A single dose of ECC4703 F3
Primary outcomes
What the sponsor says the trial is designed to measure.
- ECC4703 pharmacokinetic (PK) parameters AUC0-tlastTime frame: Up to Day 13
- ECC4703 PK parameters AUC0-infTime frame: Up to Day 13
- ECC4703 PK parameters CmaxTime frame: Up to Day 13
- ECC4703 PK parameters tmaxTime frame: Up to Day 13
- ECC4703 PK parameters AUC0-tTime frame: Up to Day 13
- ECC4703 PK parameters AUC0-24Time frame: Up to Day 13
- ECC4703 PK parameters AUCextrTime frame: Up to Day 13
- ECC4703 PK parameters tlagTime frame: Up to Day 13
- ECC4703 PK parameters t1/2Time frame: Up to Day 13
- ECC4703 PK parameters CL/FTime frame: Up to Day 13
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CMAX Clinical Research Pty Ltd
Adelaide, South Australia, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.